Every material Form 8-K WEIS MARKETS INC has filed with the SEC since August 04, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Weis Markets reported third quarter 2026 total revenue of $1.28 billion, up 3.0%, with net income of $22.21 million and earnings per share of $0.90, compared with $0.69 a year earlier. Higher fuel sales, new stores and a higher gross profit margin drove the improvement, while pharmacy pricing changes under the Inflation Reduction Act weighed on sales. The company also declared a $0.34 quarterly dividend.
Q3 2026 total revenue rose 3.0% to $1.28 billion; comparable store sales rose 1.3%, but fell 1.2% excluding fuel.
Gross profit margin rose to 25.5% from 24.8%; income from operations rose 38.6% to $28.51 million.
Year-to-date net income was $72.92 million, or $2.95 per share, versus $61.73 million, or $2.38 per share, a year earlier.
Board declared a $0.34 per share quarterly dividend, payable November 23, 2026, to holders of record as of November 9, 2026.
On October 29, 2026, Weis Markets and its subsidiaries amended their unsecured revolving credit agreement with Wells Fargo Bank. The facility provides a $30 million principal commitment, with an additional $70 million of discretionary availability, and matures on October 1, 2030. The filing says the other terms are consistent with the prior agreement and does not state any amount borrowed under the facility.
Unsecured revolving facility: $30 million aggregate principal commitment plus $70 million discretionary availability.
Maturity date is October 1, 2030; no principal payments are due before maturity.
Loans bear interest at 1.00% above Daily Simple SOFR, and an unused fee of 0.25% applies.
Company must maintain minimum EBITDA of $175 million, tested quarterly on a trailing twelve-month basis.
Weis Markets reported second-quarter 2026 revenue of $1.28 billion, up 4.6%, with comparable store sales up 2.3%. Net income fell 9.6% to $22.86 million, and earnings per share were $0.92 versus $0.96 a year earlier, so shareholders saw higher sales but lower quarterly profit. Year-to-date net income rose 13.1% to $50.71 million, with earnings per share of $2.05 versus $1.69.
Q2 total revenue $1.28 billion vs. $1.22 billion, up 4.6%; pharmacy revenue hit by about $10.71 million from Inflation Reduction Act pricing headwinds
Q2 net income $22.86 million vs. $25.28 million; EPS $0.92 vs. $0.96
Year-to-date net income $50.71 million vs. $44.83 million, up 13.1%; YTD EPS $2.05 vs. $1.69
Board declared a quarterly cash dividend of $0.34 per share, payable August 10, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every WEIS MARKETS INC filing is on SEC EDGAR ↗. 8-K briefs of other companies →